Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by Holler Frank A, Director. Officer active across 2 companies, notably Xenon Pharmaceuticals Inc.. Cumulatively, 1 filings have been published. History available since 27 May 2021. The latest transaction was filed on 27 May 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Frank A. Holler is a Board Member at Xenon Pharmaceuticals Inc. He plays a crucial role in the governance of the company, providing strategic advice and oversight of operations. His experience in the pharmaceutical sector allows him to contribute to the innovation and growth of Xenon Pharmaceuticals. As a board member, he participates in critical decision-making for the company's future.